Generics Industry News Search
 |
|
|
|
|
|
|
February 2014 News Archive |
|
|
| |
|
Endo today announced that its Qualitest subsidiary has completed the acquisition of privately held Boca Pharmacal, a specialty pharmaceutical company, for approximately $225 million in cash...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
California-based drug-maker Gilead is in discussions with a handful of local pharmaceutical companies to bring its much anticipated oral Hepatitis C drug Sovaldi (Sofosbuvir) into India...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan, has launched the world's first Trastuzumab biosimilar in India...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ferring today announced that their patents for Lysteda (Tranexamic acid), a non-hormonal prescription medicine to treat heavy monthly menstrual bleeding, have been found valid and infringed by both Watson Pharmaceuticals and Apotex...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
PDL BioPharma today announced that it has entered into an agreement with Genentech and Roche which resolves all outstanding legal disputes between the parties, including its Nevada litigation with Genentech and Roche and its arbitration proceedings with Genentech related to the audit of royalties on sales...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
AstraZeneca today announced that it completed, on 1 February 2014, the acquisition of the entirety of Bristol-Myers Squibb's interests in the companies' diabetes alliance...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis today confirmed that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market Bendamustine Hydrochloride for Injection, 25 mg/vial and 100 mg/vial...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The U.S. FDA has granted "tentative approval" to a generic formulation of Reyataz (Atazanavir) to treat HIV abroad...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sandoz today announced the US launch of Doxercalciferol injection vials, the first generic version of Genzyme's Hectorol...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pfizer, the world's largest drug maker, has beaten back generic competition for the pain medicine Lyrica...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Indian arm of Swiss pharma major Roche, which unexpectedly gave up its patent on it s $6 billion breast cancer drug Herceptin (Trastuzumab) in India last year, has sued Bangalore based Biocon and US generic giant Mylan in Delhi HC for launching world's first biosimilar version of the original drug in India...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
FDA Commissioner Margaret Hamburg said she will ask the drug firms and Indian regulators to "build new partnerships" during her visit beginning Feb. 10...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Swiss drug major Novartis has sued Dr Reddys Laboratories in an American court stating the Hyderabad-headquartered company's plan to market and sell its own version of the blockbuster cancer drug Gleevec would infringe Novartis' patent...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
In Apotex v Sanofi-Aventis [2013] HCA 50 the High Court finally confirmed (what was fairly well understood all along) that methods of medical treatment are patentable subject matter in Australia...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Indian pharmaceutical companies are interested in establishing manufacturing in Georgia. The prospect of low-priced generic drugs promises to reduce healthcare costs...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sanofi and its top-selling Lantus may have bought some time last month with a legal wrench in Eli Lilly's spokes, but now Merck has bulldozed its way into the conversation with plans to kick off late-stage studies for its own knockoff of the blockbuster drug, further complicating an already heated fight...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
With on the ongoing debate on tough regulations in the pharmaceutical
industry creating concern in the sector, Chairman of Cipla Yusuf Hamied
on Monday called for a new pragmatic drug licensing policy in the
country to cater to the needs of the Indian population...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
On her first official trip to India, the USFDA commissioner Margaret Hamburg signed a 10 point agreement with India's drug regulatory authority on Monday...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Federal prosecutors in New York are investigating Teva's sales and marketing practices for its drugs Copaxone and Azilect. Possible civil violations of the federal False Claims Act are being looked into, the company said...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Dublin-based specialty pharmaceuticals company Mallinckrodt said it will buy pain-relieving drugmaker Cadence...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mayne Pharma has begun expanding its North American product portfolio by acquiring well-known branded pharmaceuticals used to treat pain...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pfizer's Australian unit was sued by the country's competition regulator for misuse of market power relating to sales of its generic version of the Lipitor cholesterol drug...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Alvogen, the multinational pharmaceuticals company, today announced the launch of Inflectra (Infliximab) into Central and Eastern Europe...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Food and Drug Administration published consumer guidance, notifying the public that the agency has approved a generic drug combination for HIV-1 infection...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva today announced that the U.S. Food and Drug Administration has granted full approval of Synribo (Omacetaxine mepesuccinate) for injection...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sun Pharma announced that the USFDA has granted its subsidiary final approval for its abbreviated new drug application to market a generic version of Temodar, Temozolomide Capsules, 5 mg, 20 mg, 100 mg, 140 mg, 180 mg and 250 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Companies that make generic drugs, the medications most Americans buy, are fighting to kill a proposed federal regulation that would require them for the first time to warn patients of all the known health risks of each drug they sell...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Bangalore-based Biocon and US generic drugmaker Mylan have challenged Delhi High Court's interim order which barred them from using Swiss drug innovator Roche's data to sell their jointly developed biosimilar version of breast cancer drug Trastuzumab...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Novartis announced today that it is broadening its cancer immunotherapy research program with the acquisition of CoStim Pharmaceuticals...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mapi announced today that the company has been granted a United States patent for Tapentadol...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis, the world's second-largest generic-drug maker by market value, agreed to buy Forest Laboratories for about $25 billion in a deal that will transform it into a developer of brand-name drugs...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The New York Attorney General and the U.S. units of Ranbaxy and Teva have settled claims that an agreement between the two drugmakers unlawfully restricted competition...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Madrid office of global law firm Eversheds has successfully represented pharmaceutical company MSD Spain in a landmark patent dispute, setting a new precedent for patent infringement cases...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Jubilant Biosys, a Bengaluru based subsidiary of Jubilant Life Sciences, announced today that it has expanded its drug discovery alliance with Janssen...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Food and Drug Administration has begun the nation's first widespread testing program for generic drugs that make up almost 80 percent of U.S. prescriptions...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva won the backing of a European Medicines Agency committee for a new version of lung therapy Symbicort, paving the way for competition to one of AstraZeneca's best-selling drugs...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Amarin, announced today that the U.S. Food and Drug Administration has awarded three years of marketing exclusivity to Vascepa (Icosapent ethyl) capsules in connection with the July 26, 2012 approval of Vascepa pursuant to the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sun gain after the company got U.S. Food and Drug Administration approval to sell a drug to treat osteoporosis, a bone-weakening disease...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Forest Laboratories, which is being acquired by Actavis, was sued by a shareholder who claims the transaction provides investors with an inadequate return...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
As competition in its traditional businesses intensifies, CCM Duopharma Biotech (CCMD) is leveraging on a partnership with a South Korean pharmaceutical company to get a new source of revenue....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Regeneron today announced that the U.S. Food and Drug Administration has accepted for standard review the Company's supplemental Biologics License Application for Eylea (Aflibercept) Injection for the treatment of Macular Edema following Branch Retinal Vein Occlusion...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Dr. Reddy's announced today that it has launched Sumatriptan injection USP, autoinjector system 6 mg/0.5 mL...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pharma major Lupin announced today that it has received final approval for its Rifabutin capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The way is now clear for the Bayer Group to acquire Norwegian pharmaceutical company Algeta. On expiration of the offer deadline on February 26, 2014 at 09:00 CET, Bayer had received acceptances for the voluntary takeover offer for a total of approximately 42,731,347 shares, representing approximately 97.28 % of Algeta's share capital...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Impax is facing a government probe over the powerful painkiller drug Opana ER and its generic equivalents, the company said in a regulatory filing Wednesday...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
India based generic drug maker Cipla has received FDA tentative approval for a generic formulation of Emtricitabine and Tenofovir disoproxil fumarate tablets, 200 mg/300 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Bayer plans to acquire 100 per cent of the shares of Dihon Pharmaceutical Group, Kunming Yunnan, China, a privately held pharmaceutical company specializing primarily in OTC and herbal traditional Chinese medicine (TCM) products...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Dronedarone Hydrochloride Tablets 400 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Colchicine Tablets USP, 0.6 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
